NS
SRPT icon

NBC Securities’s Sarepta Therapeutics SRPT Stock Holding History

NBC Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50
Closed -$3K – 2532
2025
Q1 		$3K Buy
+50
New +$5.26K ﹤0.01% 1992
2024
Q4 		– Sell
-100
Closed -$12K – 1969
2024
Q3 		$12K Hold
100
– – ﹤0.01% 1679
2024
Q2 		$15K Hold
100
– – ﹤0.01% 1556
2024
Q1 		$12K Sell
100
-6,010
-98% -$736K ﹤0.01% 1638
2023
Q4 		$589K Sell
6,110
-50
-0.8% -$4.8K 0.06% 358
2023
Q3 		$746K Buy
+6,160
New +$696K 0.08% 259

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

NBC Securities's SRPT Position: Q2 2025 in Review

NBC Securities sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 50 shares — an estimated $3K sold.

NBC Securities first reported a position in SRPT in Q3 2023 and held it in 6 quarters. The position peaked at $746K in Q3 2023. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • NBC Securities reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • NBC Securities sold 50 Sarepta Therapeutics shares in Q2 2025, an estimated $3K.
  • NBC Securities first reported a position in Sarepta Therapeutics in Q3 2023 and held it in 6 quarters.
  • NBC Securities's Sarepta Therapeutics position peaked at $746K in Q3 2023.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on NBC Securities's 13F filing for Q2 2025, filed 8 Jul 2025.